Joseph M. Martinez

University of California, Davis — United States

Neuroscience · Life Sciences

18h-index1.2kcitations35works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroinflammation and Neurodegeneration Mechanisms(9), Barrier Structure and Function Studies(8), Neurological Disease Mechanisms and Treatments(8), Receptor Mechanisms and Signaling(7), Pain Mechanisms and Treatments(4)

Publications35 total

Stimulation of Ca <sup>2+</sup> channel Ca <sub>V</sub> 1.2 activity by dopamine signaling augments spatial working memory
Science Signaling·2025Open Access
Arrestin-dependent nuclear export of phosphodiesterase 4D promotes GPCR-induced nuclear cAMP signaling required for learning and memory
Science Signaling·2023· 14 citedOpen Access
Endosomal b2‐adrenergic receptor controls nuclear cAMP signal in learning and memory via sequestration of phosphodiesterase 4D
The FASEB Journal·2022
The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
Frontiers in Pharmacology·2021· 140 citedOpen Access
GRK Regulation of Beta2 Adrenergic Receptor Mediated Gene Transcription: Impacts on Learning and Memory
The FASEB Journal·2020
β-blockers augment L-type Ca2+ channel activity by targeting spatially restricted β2AR signaling in neurons
eLife·2019· 16 citedOpen Access
Author response: β-blockers augment L-type Ca2+ channel activity by targeting spatially restricted β2AR signaling in neurons
2019Open Access
Author response: β-blockers augment L-type Ca2+ channel activity by targeting spatially restricted β2AR signaling in neurons
2019Open Access
β-blockers augment L-type Ca <sup>2+</sup> channel activity by target-selective spatially restricted β <sub>2</sub> AR-cAMP-PKA signaling in neurons
2019Open Access
Clinical Application of Polysialylated Deoxyribonuclease and Erythropoietin
Recent Patents on Drug Delivery & Formulation·2018· 14 cited
[FTS3–01–04]: VASCULAR‐MEDIATED NEUROTOXICITY: A NOVEL TARGET FOR AD THERAPEUTICS
Alzheimer s & Dementia·2017· 1 cited
Effective Reduction in High Ethanol Drinking by Semisynthetic Tetracycline Derivatives
Alcoholism Clinical and Experimental Research·2016· 22 citedOpen Access
Binge Ethanol Consumption Increases Inflammatory Pain Responses and Mechanical and Cold Sensitivity: Tigecycline Treatment Efficacy Shows Sex Differences
Alcoholism Clinical and Experimental Research·2016· 38 citedOpen Access
Effective Reduction of Acute Ethanol Withdrawal by the Tetracycline Derivative, Tigecycline, in Female and Male<scp>DBA</scp>/2J Mice
Alcoholism Clinical and Experimental Research·2016· 19 citedOpen Access
The Cstf2t Polyadenylation Gene Plays a Sex-Specific Role in Learning Behaviors in Mice
PLoS ONE·2016· 18 citedOpen Access
Antinociceptive effects of synthetic tetracycline compound and influence of Cx3cr1 in inflammatory pain
The FASEB Journal·2016· 1 cited
(299) Gender-specific pain responses in the formalin test using a synthetic tetracycline compound
Journal of Pain·2016· 1 citedOpen Access
(357) Antinociceptive effects of a synthetic tetracycline compound on mechanical and cold allodynia
Journal of Pain·2016Open Access
Targeting Thrombin: An Inflammatory Neurotoxin in Alzheimer's Disease
Journal of Alzheimer s Disease·2014· 43 cited
A New Paradigm for the Treatment of Alzheimer's Disease: Targeting Vascular Activation
Journal of Alzheimer s Disease·2014· 73 cited
page 1 of 2Next →

Frequent Co-authors

Paula Grammas(15), Debjani Tripathy(11), Alma Sanchez(11), Xiangling Yin(10), Susan E. Bergeson(7), Ao Shen(7), Yang K. Xiang(7), Johannes Hell(6), Patrick Marquardt(6), Bing Xu(6), Jinhua Luo(5), David C. Curtis(5), Kwun Nok Mimi Man(5), Manuel F. Navedo(5), Henry Blanton(4), Caitlyn Sherfey(4), Christian Bezboruah(4), Josée Guindon(4), Dana Chen(4), Peter H. Bartels(4)